Literature DB >> 10323790

Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells.

B A Allison1, L Nilsson, F Karpe, A Hamsten, P Eriksson.   

Abstract

Whereas VLDL has consistently been shown to induce a concentration-dependent increase in the expression of plasminogen activator inhibitor-1 (PAI-1) in human umbilical vein endothelial cells (HUVECs) and liver cells, variable effects have been reported for native and oxidatively modified LDL. In the present study, activation of PAI-1 protein and mRNA expression by native LDL (nLDL), UV-oxidized LDL (uvLDL), and triglyceride (TG)-enriched LDL was studied in HUVECs by using different incubation times and a wide range of lipoprotein concentrations. No significant increase of PAI-1 protein expression was observed after 4 hours of incubation with nLDL or uvLDL. However, PAI-1 protein secretion from HUVECs was markedly enhanced after 18 hours of incubation with uvLDL (200% increase at 10 microg/mL). Stimulation of PAI-1 protein expression in HUVECs by nLDL was seen, however, after increasing the TG content of the LDL particle. LDL enriched in phospholipid had no effect on PAI-1 secretion. PAI-1 mRNA levels on northern blot increased in parallel with the activation of PAI-1 protein expression by native and modified forms of LDL. Low concentrations of TG-enriched LDL (10 microg/mL) and higher concentrations of nLDL and uvLDL (100 microg/mL) were found to increase the binding of a VLDL-inducible transcription factor to the PAI-1 promoter. These results indicate that the TG content of the LDL particle influences PAI-1 expression in endothelial cells. Low concentrations of uvLDL enhanced PAI-1 protein and mRNA expression in the HUVECs after an 18-hour incubation but did not influence the VLDL-inducible transcription factor. This suggests that low levels of oxidized LDL increase PAI-1 expression by a different mechanism than VLDL and TG-enriched LDL.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323790     DOI: 10.1161/01.atv.19.5.1354

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  7 in total

1.  Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks.

Authors:  Chad L Cox; Kimber L Stanhope; Jean Marc Schwarz; James L Graham; Bonnie Hatcher; Steven C Griffen; Andrew A Bremer; Lars Berglund; John P McGahan; Nancy L Keim; Peter J Havel
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

2.  Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1.

Authors:  V A Ploplis; I Cornelissen; M J Sandoval-Cooper; L Weeks; F A Noria; F J Castellino
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

Review 3.  Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells.

Authors:  Garry X Shen
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

4.  Transcriptional regulation of plasminogen activator inhibitor-1 in vascular endothelial cells induced by oxidized very low density lipoproteins.

Authors:  Ruozhi Zhao; Xiuli Ma; Garry X Shen
Journal:  Mol Cell Biochem       Date:  2008-07-03       Impact factor: 3.396

5.  Dietary fat differentially influences the lipids storage on the adipose tissue in metabolic syndrome patients.

Authors:  Antonio Camargo; Maria E Meneses; Pablo Perez-Martinez; Javier Delgado-Lista; Yolanda Jimenez-Gomez; Cristina Cruz-Teno; Francisco J Tinahones; Juan A Paniagua; Francisco Perez-Jimenez; Helen M Roche; Maria M Malagon; Jose Lopez-Miranda
Journal:  Eur J Nutr       Date:  2013-08-07       Impact factor: 5.614

6.  Effects on blood glucose, insulin, lipid and proatherosclerotic parameters in stable type 2 diabetic subjects during an oral fat challenge.

Authors:  Chung-Jung Wu; Zer-Ran Yu
Journal:  Lipids Health Dis       Date:  2004-07-20       Impact factor: 3.876

Review 7.  The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts.

Authors:  Giuseppe Maiolino; Giacomo Rossitto; Paola Caielli; Valeria Bisogni; Gian Paolo Rossi; Lorenzo A Calò
Journal:  Mediators Inflamm       Date:  2013-10-03       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.